Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only Get Premium

BEAT HeartBeam Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: BEAT

Price (delayed)

$1.32

Market cap

$44.62M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.74

Enterprise value

$40.23M

HeartBeam, Inc., a medical technology company, primarily focuses on telemedicine solutions for the detection and monitoring of cardiac disease outside a healthcare facility setting. The company also focuses on providing ...

Highlights
BEAT's quick ratio has dropped by 55% year-on-year
The equity has declined by 40% year-on-year
Sector: Healthcare
Industry: Health Information Services
Website: https://www.heartbeam.com
Peers: TDOC VEEV OMCL HSTM

Key stats

What are the main financial stats of BEAT
Market
Shares outstanding
33.81M
Market cap
$44.62M
Enterprise value
$40.23M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
5.91
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
Gross profit
$0
Operating income
-$20.61M
Net income
-$20.33M
EBIT
-$20.33M
EBITDA
-$20.31M
Free cash flow
-$15.6M
Per share
EPS
-$0.74
EPS diluted
-$0.74
Free cash flow per share
-$0.51
Book value per share
$0.22
Revenue per share
$0
TBVPS
$0.3
Balance sheet
Total assets
$9.11M
Total liabilities
$1.58M
Debt
$0
Equity
$7.53M
Working capital
$7.03M
Liquidity
Debt to equity
0
Current ratio
5.46
Quick ratio
5.16
Net debt/EBITDA
0.22
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-278.8%
Return on equity
-358.3%
Return on invested capital
-8,146.7%
Return on capital employed
-270%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

BEAT stock price

How has the HeartBeam stock price performed over time
Intraday
1.54%
1 week
7.76%
1 month
-20%
1 year
-50%
YTD
-42.61%
QTD
5.6%

Financial performance

How have HeartBeam's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$20.61M
Net income
-$20.33M
Gross margin
N/A
Net margin
N/A
BEAT's net income is down by 35% year-on-year and by 4.5% since the previous quarter
The operating income has contracted by 29% YoY and by 3.6% from the previous quarter

Price vs fundamentals

How does BEAT's price correlate with its fundamentals

Growth

What is HeartBeam's growth rate over time

Valuation

What is HeartBeam stock price valuation
P/E
N/A
P/B
5.91
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
BEAT's EPS is down by 25% YoY
The price to book (P/B) is 65% lower than the last 4 quarters average of 16.7
The equity has declined by 40% year-on-year

Efficiency

How efficient is HeartBeam business performance
HeartBeam's return on equity has decreased by 28% QoQ
The company's return on assets fell by 21% QoQ

Dividends

What is BEAT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for BEAT.

Financial health

How did HeartBeam financials performed over time
HeartBeam's total assets has surged by 178% QoQ but it has decreased by 33% YoY
The current ratio has shrunk by 55% YoY
HeartBeam's debt is 100% less than its equity
The equity has declined by 40% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.